The criteria for diagnosis of polycystic ovary syndrome (PCOS) have been modified and now include polycystic ovary morphology (PCOM). The purpose of this study was to determine the frequency of PCOS and PCOM in women with type 1 diabetes mellitus (DM1). We evaluated the clinical, hormonal, and ultrasonographic characteristics in women with DM1 and compared them with a carefully matched group of normal women in a cross-sectional study. The study was conducted at an academic research institute located within a general hospital. All the women with DM1 attending our hospital who had experienced menarche at least 2.5 yr earlier were invited to participate and were compared with healthy women with regular menses and without a history of hyperandrogenism [controls (C)]. Hirsutism was present in 28.6 and 0.0% of DM1 and C, respectively (P < 0.001). Biochemical hyperandrogenism was present in 23.8 and 7.9% of DM1 and C, respectively. DM1 women had higher levels of testosterone and androstenedione and larger ovarian volume and follicle number by ovary than C. PCOM was present in 54.8% of DM1 and 13.2% of C (P < 0.001). Oligomenorrhea was present in 19% of women with DM1. The frequency of PCOS was 40.5 and 2.6% in DM1 and C, respectively ...Continue Reading
The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome
Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming
The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today?
Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus
Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index
Bone mass and sex steroids in postmenarcheal adolescents and adult women with Type 1 diabetes mellitus
Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus
The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes
Racial differences in self-reported infertility and risk factors for infertility in a cohort of black and white women: the CARDIA Women's Study
The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Other complications and associated conditions
Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus
Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus
ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents
Testicular function during adolescence in boys with type 1 diabetes mellitus (T1D): absence of hypogonadism and differences in endocrine profile at the beginning and end of puberty
Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women
Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy
High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile
ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes
Effects of Nigella sativa oil on ovarian volume, oxidant systems, XIAP and NF-kB expression in an experimental model of diabetes
Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus
Obesity, menstrual irregularity and polycystic ovary syndrome in young women with type 1 diabetes: A population-based study.
Falsely elevated testosterone in a type 1 diabetes patients with acne and chronic renal failure on dialysis
Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls
Autoimmune Diabetes & Tolerance
Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.